Log In
BCIQ
Print this Print this
 

AST-106, TH-3424

  Manage Alerts
Collapse Summary General Information
Company Threshold Pharmaceuticals Inc.
DescriptionProdrug which selectively releases a DNA bis-alkylating agent upon exposure to aldo-keto reductase family 1 member C3 (AKR1C3)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/19/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today